| Application: | Internal Medicine |
|---|---|
| Usage Mode: | For oral administration |
| State: | Solid |
| Shape: | Capsules |
| Type: | Organic Chemicals |
| Payment Item: | Tt |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
OMPOSITION
2mg loperamide hydrochloride per capsule
PHARMACOLOGICAL CLASSIFICATION
Medicines acting on gastro-intestinal tract. Antidiarrhoeals.
PHARMACOLOGICALACTION
PERATOR CAPS inhibits hypermotility by direct action on the bowel wall. Its inhibition of peristalsis is the result of decreasing the activity of both the longitudinal museles (preparatory and reflex phases) and the circular muscles (reflex phase).
PERATOR CAPS normalizes the stool in both acute and chronic diarrhoea.
PERATOR CAPS is incompletely absorbed from the gut, and it is almost completely metabolized in the liver where it is conjugated and excreted via the bile.
PERATOR CAPS is mainly eliminated via the faeces.
INDICATIONS
Adults and children 6 years and older: PERATOR CAPS is indicated for the control and symptomatic relief of acute and chronic nonspecific diarrhoea and inhibition of peristalsis and slowing of intestinal transit time in patients with ileostomies, colostomies and other intestinal resections.
Children below 6 years of age: PERATOR CAPS is indicated for inhibition of peristalsis and slowing intestinal transit time.
CONTRA-INDICATIONS
PERATOR CAPS is contra-indicated in patients with a known hypersensitivity to the medicine.
PERATOR CAPS is contra-indicated in infants under 24 months of age.
Since treatment of diarrhoea with PERATOR CAPS is only symptomatic, diarrhoea should be treated causally, whenever causal treatment is available. PERATOR CAPS should not be used as the primary therapy in acute dysentery, which is characterised by blood in stools and high fever. PERATOR CAPS must not be used in patients with acute ulcerative colitis or pseudomembranous colitis associated with broad-spectrum antibiotics. In general, PERATOR CAPS should not be used when inhibition of peristalsis is to be avoided and must be discontinued promptly if constipation, abdominal distension or subileus develop. Loperamide administration may precipitate toxic megacolon in patients with inflammatory bowel disease.
The safety of use during pregnancy and lactation has not been established.
Qingdao Tianpu Medical Technology Co., LTD. comprehensive business involves: Importing, Exporting, R&D, OEM and Joint production. We are your best choice to get one-stop overall solution service from China. We have the advantage of many famous brands of domestic products agency, customer as the center, from the actual needs of customers, to provide them with truly valuable products and services. We are responsible and committed team that ensures your requirements will be promptly and fully met. Please contact us about your requirements.We are not only promoting our products, but also emphasizing on providing professional techniques and good services. Customer satisfaction and prompt delivery are two aims that we never change. Good reputation is our strong backbone. Because of this, we maintain our reputation with excellent quality and prompt delivery service.
We sincerely hope we can have long-term cooperation with you for mutual benefits; the common benefits between us can achieve the biggest profits. Qingdao Tianpu welcome to you and visting.
1. Mixed container, we can mix different items in one container.
2. Quality control, before shipment, free sample for test. After shipment, keep sample for 3 years
3. Prompt shipment with professional documents
4. Packing as your request, with photo before shipment
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}